Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy Phase I/II

NCT00424151 is registered in ClinicalTrials.gov with Silkiss, Rona Z., M.D., FACS as lead sponsor.

NCT NCT00424151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00424151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy Phase I/II
Lead sponsor
Silkiss, Rona Z., M.D., FACS
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2009
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graves' dysthyroid ophthalmopathy, thyroid related orbitopathy